UC Conducting A Clinical Trial On A New Drug To Protect Individuals From HIV Infection

Researchers at the University of Cincinnati are conducting a clinical trial to determine if a new drug, cabotegravir (CAB) , is a safe and effective method of protection from HIV. The UC clinical trial is part of a study being done by the HIV Prevention Trials Network .